Categories: News

Hisense Will Lead a Human-Centric Display Evolution at CES 2026

QINGDAO, China, Dec. 18, 2025 /PRNewswire/ — Hisense, a leading brand in global consumer electronics and home appliances, will arrive at CES 2026 with its global theme “Innovating A Brighter Life,” presenting a future where display innovation is defined by a more human-centric approach. For Hisense, this theme reflects an enduring commitment to designing technologies that elevate everyday life—making screens more natural to view, more sustainable to use, and more emotionally engaging in the home.

- Advertisement -

This vision will be anchored by Hisense’s latest evolution of RGB MiniLED. The real upgrade of the technology will deliver next-level color performance with improved eye comfort and enhanced energy efficiency. As The Origin of RGB MiniLED, Hisense is rethinking the light engine from its very source — guiding the industry into a new era of displays while continuing to push technological boundaries.

- Advertisement -

Beyond display technology, Hisense will also showcase its latest AI-powered home appliances and next-generation engineering innovations, illustrating how intelligent, connected systems will shape the future of modern living. These innovations reflect Hisense’s holistic belief that a brighter life is created not by isolated products but by an ecosystem designed around real human needs.

- Advertisement -

Through “Innovating A Brighter Life,” Hisense will demonstrate at CES that the future of screens will be designed for people first—and that the new era of display excellence will begin with RGB MiniLED innovation.

- Advertisement -

Press Conference
Date & Time: Monday, January 5, 2026 – 10:00 AM PST
Location: South Convention Center, South Seas Ballroom F, Las Vegas, NV

- Advertisement -

Hisense Booth at CES 
Dates: January 6–9, 2026
Location: Booth #17704, Central Hall, Las Vegas Convention Center, Las Vegas, NV

- Advertisement -

About Hisense

- Advertisement -

Hisense, founded in 1969, is a globally recognized leader in home appliances and consumer electronics with operations in over 160 countries, specializing in delivering high-quality multimedia products, home appliances, and intelligent IT solutions. According to Omdia, Hisense ranks No. 1 globally in the 100-inch and over TV segment (2023- Q3 2025). As the official sponsor of the FIFA World Cup 2026™, Hisense is committed to global sports partnerships as a way to connect with audiences worldwide.

- Advertisement -

Photo – https://mma.prnewswire.com/media/2845285/Hisense_Will_Lead_a_Human_Centric_Display_Evolution_at_CES_2026.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/hisense-will-lead-a-human-centric-display-evolution-at-ces-2026-302642195.html

- Advertisement -

Recent Posts

Crypto News: AlphaPepe Presale Records Surge in Whale Accumulation As Bitcoin Price Prediction Eyes $180,000

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe after the…

47 minutes ago

Crypto Market News: AlphaPepe Finalizes Tier-1 Exchange Shortlist as XRP Price Prediction Targets $5.00

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto market news is turning toward AlphaPepe after…

47 minutes ago

Qoder Version 1.0 Released: Full Automation of Code Generation, Verification & Delivery

SINGAPORE, May 16, 2026 (GLOBE NEWSWIRE) -- Qoder officially releases version 1.0, upgrading from an…

47 minutes ago

Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction

Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to placeboAt Week 24, 60.8% of patients treated with corabotase experienced clinically…

48 minutes ago

ImPact Biotech Presents Updated Data from Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC at AUA 2026

– Complete response (CR) observed in 70% (50/72) of evaluable patients with low-grade upper tract…

48 minutes ago

Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers

- Stenoparib clinical development continues in relapsed small cell lung cancer and, under FDA Fast…

48 minutes ago